Medford, MA · Founded 2021 · Privately Held (backing)
Operator of a therapeutic biotechnology company intended for developing oral neurorestorative therapies aimed at reversing key pathologies underlying brain dysfunctions and central nervous system… Myrobalan Therapeutics is based in Medford, MA and was founded in 2021. It has raised $43 million.
Last price · $/share
—
Implied valuation
—
Total raised
$43.0M
Last round
—
No prints on record
No secondary trades in Myrobalan Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Myrobalan Therapeutics with a free Private Market View account
·Watch Myrobalan Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Myrobalan Therapeutics stock.
